CA
GMAB icon

Cliff Asness’s Genmab GMAB Stock Holding History

Cliff Asness’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.91M Buy
106,104
+22,825
+27% +$607K ﹤0.01% 2372
2026
Q1 		$2.23M Buy
83,279
+1,052
+1% +$31.5K ﹤0.01% 2273
2025
Q4 		$2.53M Buy
82,227
+8,526
+12% +$266K ﹤0.01% 1987
2025
Q3 		$2.26M Buy
73,701
+43,738
+146% +$1.07M ﹤0.01% 1906
2025
Q2 		$619K Buy
+29,963
New +$615K ﹤0.01% 2486

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cliff Asness's GMAB Position: Q2 2026 in Review

Cliff Asness increased its Genmab (GMAB) stake by 27% in Q2 2026, buying an estimated $607K and bringing the position to 106,104 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2372.

Cliff Asness first reported a position in GMAB in Q2 2025 and has held it in 5 quarters since. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Cliff Asness held 106,104 shares of Genmab worth $2.91M as of Q2 2026.
  • Cliff Asness bought 22,825 Genmab shares in Q2 2026, an estimated $607K.
  • Genmab made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2372 holding.
  • Cliff Asness first reported a position in Genmab in Q2 2025 and has held it in 5 quarters since.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.